Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 419, 545-546 (10 October 2002) | doi:10.1038/419545a
Regulators split on gene therapy as patient shows signs of cancer
Erika Check
The revelation last week that experimental gene therapy may have given a child a cancer-like illness has provoked diverse regulatory responses around the world.The child was involved in a trial to treat severe combined immunodeficiency disease (SCID), a condition that disrupts the early development of the immune system.
To read this story in full you will need to login or make a payment (see right).